Drugs for Gastrointestinal Diseases Practice Questions

Q: Which of the following is not an adverse effect of cimetidine?

Decreased prolactin levels. ***Decreased prolactin levels*** - Cimetidine, an **H2 receptor antagonist**, is known to **increase prolactin levels** due to its anti-androgenic effects and effects on dopamine regulation, not decrease them. - This elevation in prolactin can lead to side effects such as **galactorrhea** and **gynecomastia**. *Confusional state, restlessness* - Cimetidine can cross the **blood-brain barrier** and block H2 receptors in the central nervous system, leading to **CNS side effects** like confusion, disorientation, agitation, and hallucinations, especially in elderly patients or those with renal impairment. - These effects are less common with newer H2 blockers that have lower CNS penetration. *Gynecomastia* - Cimetidine has **anti-androgenic effects** by binding to androgen receptors and inhibiting the metabolism of estrogens, which can lead to an increase in estrogen-to-androgen ratio. - This imbalance can result in increased breast tissue development in males, known as **gynecomastia**, and also **sexual dysfunction**. *Dry mouth* - Dry mouth is **not a recognized adverse effect** of cimetidine, as H2 receptor antagonists do not possess anticholinergic properties [1]. - Unlike anticholinergic drugs that block muscarinic receptors [1], cimetidine specifically blocks histamine H2 receptors and does not interfere with salivary secretion. - This option may serve as a distractor, as dry mouth is commonly associated with other drug classes but not with H2 blockers [1].

Q: Which of the following is a Cl- channel activator related to gastrointestinal conditions?

Lubiprostone. **Lubiprostone** - Lubiprostone is a **prostanoid derivative** that specifically activates **chloride channels (ClC-2)** in the apical membrane of gastrointestinal epithelial cells [1]. - This activation leads to increased fluid secretion into the intestinal lumen, softening stool and promoting bowel movements, making it useful for treating **chronic idiopathic constipation (CIC)** and **irritable bowel syndrome with constipation (IBS-C)** [1]. *Nefazodone* - Nefazodone is an **antidepressant** that acts as a **serotonin 5-HT2 and alpha-1 adrenergic receptor antagonist**, and also inhibits serotonin and norepinephrine reuptake. - Its primary therapeutic use is in the treatment of **depression**, and it does not directly act as a chloride channel activator for gastrointestinal conditions. *Varenicline* - Varenicline is a **nicotinic acetylcholine receptor partial agonist** used primarily for **smoking cessation**. - It reduces cravings and withdrawal symptoms associated with nicotine addiction, with no direct action on chloride channels in the gastrointestinal tract. *Valethamate* - Valethamate is an **anticholinergic and antispasmodic agent** sometimes used to relieve smooth muscle spasms in the gastrointestinal or genitourinary tracts. - It works by blocking muscarinic receptors and does not directly activate chloride channels to promote fluid secretion.

Q: Which of the following is not considered a prokinetic agent?

Diphenylmethane. Diphenylmethane derivatives (e.g., bisacodyl, sodium picosulfate) are stimulant laxatives, not prokinetic agents. While they do increase colonic motility, they work by direct stimulation of the colonic mucosa and myenteric plexus, causing increased water secretion and peristalsis [3]. Prokinetic agents specifically enhance coordinated gastrointestinal motility through modulation of neurotransmitters (acetylcholine, dopamine, serotonin, motilin), whereas laxatives work through different mechanisms (osmotic effects, stimulation, bulk formation). Therefore, diphenylmethane derivatives are classified as laxatives, not prokinetics. Dopamine antagonist - Dopamine antagonists like metoclopramide and domperidone block D2 receptors in the chemoreceptor trigger zone and GI tract, enhancing acetylcholine release and promoting gastric emptying [2]. - They are commonly used as prokinetic agents and antiemetics [2]. 5HT4 agonist - 5HT4 agonists (e.g., cisapride, prucalopride) stimulate serotonin receptors in the enteric nervous system, increasing acetylcholine release and enhancing colonic motility [1]. - They are effective prokinetic agents for conditions like chronic constipation and gastroparesis [1]. Macrolides - Certain macrolide antibiotics, such as erythromycin, act as motilin receptor agonists at sub-antibiotic doses. - By mimicking motilin, they stimulate gastric and intestinal contractions (phase III of migrating motor complex), functioning as prokinetic agents.

Q: What is the drug of choice (DOC) for prophylaxis of motion sickness?

Promethazine. ***Promethazine*** - **Promethazine** is an antihistamine with significant anticholinergic properties, making it highly effective for preventing **motion sickness**. - It acts by blocking **H1 histamine receptors** and **muscarinic acetylcholine receptors** in the brainstem and vestibular pathways. *Prochlorperazine* - **Prochlorperazine** is a **dopamine D2 receptor antagonist** primarily used for severe nausea and vomiting. - While it has some efficacy against nausea, it is generally **less effective** than anticholinergics or antihistamines for motion sickness prophylaxis. *Metoclopramide* - **Metoclopramide** is a **dopamine D2 receptor antagonist** and a **serotonin 5-HT4 receptor agonist**, which primarily increases gastrointestinal motility. - Its antiemetic action is mainly confined to conditions like **gastroparesis** and chemotherapy-induced nausea, and it is largely ineffective for **motion sickness**. *Itopride* - **Itopride** is a **dopamine D2 receptor antagonist** and an **acetylcholinesterase inhibitor**, used to treat functional dyspepsia by enhancing gastric motility. - It has **no significant role** in the prevention or treatment of **motion sickness**.

Q: What is the primary use of Pirenzepine?

Gastric ulcer. ***Gastric ulcer*** - **Pirenzepine** is a selective **M1 muscarinic antagonist** used to block acetylcholine's effects on gastric parietal cells. - By inhibiting M1 receptors, it **reduces gastric acid secretion**, thus facilitating the healing of gastric ulcers. *Glaucoma* - **Glaucoma** treatment primarily involves reducing intraocular pressure, often with **beta-blockers** or **prostaglandin analogs**. - Pirenzepine's mechanism of action is irrelevant to the **pathophysiology of glaucoma**. *Hypertension* - **Hypertension** is managed by various classes of drugs that target blood pressure regulation, such as **ACE inhibitors** or **calcium channel blockers**. - Pirenzepine does not have a direct role in the **management of blood pressure**. *Congestive cardiac failure* - **Congestive cardiac failure** treatment focuses on improving cardiac output and reducing fluid overload with drugs like **diuretics** or **ACE inhibitors**. - Pirenzepine has no therapeutic application in the **treatment of heart failure**.

Q: What is the drug of choice for preventing chemotherapy-induced vomiting?

Granisetron. ***Granisetron*** - As a **5-HT3 receptor antagonist**, granisetron is highly effective in blocking serotonin-mediated nausea and vomiting caused by chemotherapy. - It works by blocking serotonin receptors in the **chemoreceptor trigger zone** and the **gastrointestinal tract**, which are key sites for chemotherapy-induced emesis. *Prazosin* - This drug is an **alpha-1 adrenergic blocker** primarily used for hypertension and benign prostatic hypertrophy. - It has no significant antiemetic properties and is not indicated for preventing chemotherapy-induced vomiting. *Clonidine* - **Clonidine** is an **alpha-2 adrenergic agonist** typically used for hypertension, ADHD, and withdrawal syndromes. - It does not act on the pathways responsible for chemotherapy-induced nausea and vomiting. *Dimenhydrinate* - **Dimenhydrinate** is an **antihistamine** with antiemetic properties primarily used for motion sickness and mild nausea. - While it can help with some forms of nausea, it is generally not potent enough to prevent the severe vomiting induced by highly emetogenic chemotherapy.

Q: Main function of sodium citrate in ORS?

To correct Acidosis. ***To correct Acidosis*** - **Sodium citrate** provides a source of **bicarbonate** precursor, which helps to correct the **metabolic acidosis** often associated with severe dehydration and diarrhea. - In the body, citrate is metabolized into bicarbonate, raising the blood pH and counteracting the effects of acidosis. *To increase absorption of glucose by cotransport* - The absorption of glucose and sodium is coupled, meaning the presence of **sodium enhances glucose absorption** through the **SGLT1 cotransporter**. - While sodium is essential for glucose absorption, **citrate's primary role is not this direct cotransport mechanism**. *To correct electrolyte imbalance* - ORS formulations contain various electrolytes like **sodium chloride** and **potassium chloride** to rectify electrolyte imbalances caused by diarrhea. - While sodium citrate contributes to sodium levels, its specific function goes beyond just general electrolyte correction to address the **acid-base balance**. *To correct dehydration* - The overall purpose of ORS is to **rehydrate the patient** by providing fluids and electrolytes, which helps restore circulating volume. - While citrate is a component of ORS, **rehydration also depends on the water and other salts** present in the solution, not solely on citrate.

Q: Which of the following medications is classified as a stool softener?

Docusates. **Docusates** - **Docusates** (e.g., docusate sodium, docusate calcium) are **stool softeners** that work by reducing the surface tension of stool, allowing water and lipids to penetrate. - This increases the water content in the stool, making it softer and easier to pass, which is particularly useful in preventing straining after surgery or in conditions like hemorrhoids. *Bran* - **Bran** is a **bulk-forming laxative**, a type of dietary fiber that adds mass to the stool. - It absorbs water in the intestines, which increases stool volume and stimulates bowel movements, but it does not directly soften the stool in the same way docusates do. *Senna* - **Senna** is a **stimulant laxative** that works by irritating the bowel wall to promote peristalsis and bowel evacuation. - While it can help move stool, it does not act primarily by softening it, and prolonged use can lead to dependency or electrolyte imbalances. *Phenolphthalein* - **Phenolphthalein** is a **stimulant laxative** that was historically used to promote bowel movements. - It is no longer widely used due to concerns about potential carcinogenicity and other adverse effects, and it does not function as a stool softener.

Q: Which of the following drugs is not used for the treatment of H. Pylori?

Domperidone. ***Correct: Domperidone*** - Domperidone is a **prokinetic drug** used to treat nausea, vomiting, and gastric motility disorders, but it has **no direct antibacterial activity** against *H. pylori*. - It works by blocking **dopamine receptors** in the chemoreceptor trigger zone and peripherally. - Therefore, it is **NOT used for *H. pylori* eradication**. *Incorrect: Bismuth* - **Bismuth subsalicylate** is a key component of **quadruple therapy** for *H. pylori* eradication, particularly in cases of antibiotic resistance or treatment failure. - It has **bactericidal effects** against *H. pylori*, disrupts its cell wall, and inhibits its adherence to the gastric mucosa. *Incorrect: Amoxicillin* - **Amoxicillin** is a penicillin-class antibiotic commonly used in various *H. pylori* eradication regimens, including **triple therapy**. - It acts by **inhibiting bacterial cell wall synthesis**, leading to bacterial lysis. *Incorrect: Clarithromycin* - **Clarithromycin** is a macrolide antibiotic frequently included in standard **triple therapy** for *H. pylori* eradication. - It inhibits **bacterial protein synthesis** by binding to the 50S ribosomal subunit.

Q: What is the drug of choice for drug-induced peptic ulcer?

Proton pump inhibitors. ***Proton pump inhibitors*** - **PPIs** are the most effective agents for treating and preventing **NSAID-induced peptic ulcers** by profoundly suppressing gastric acid secretion. - They provide **rapid symptom relief** and promote ulcer healing by creating an environment conducive to mucosal repair. *Prostaglandin analogues* - **Misoprostol**, a prostaglandin E1 analogue, can prevent NSAID-induced ulcers, but its use is limited by **gastrointestinal side effects** such as diarrhea and abdominal cramping. - While they protect the gastric mucosa, their efficacy in healing established ulcers is generally **inferior to PPIs**. *H2-receptor antagonists* - **H2-blockers** are effective in reducing gastric acid, but they are **less potent** than PPIs and typically do not heal **gastric ulcers** as effectively, especially those induced by NSAIDs. - They are more commonly used for preventing **duodenal ulcers** and managing symptoms of GERD. *Antacids* - Antacids provide **immediate, temporary relief** of ulcer symptoms by neutralizing existing stomach acid. - They do not address the underlying pathology or promote **ulcer healing** and are therefore not considered the drug of choice for treatment.

Question 1

Which of the following is not an adverse effect of cimetidine?

Accepted Answer

Decreased prolactin levels

Answer

Gynecomastia

Answer

Dry mouth

Answer

Confusional state, restlessness

Question 2

Which of the following is a Cl- channel activator related to gastrointestinal conditions?

Accepted Answer

Lubiprostone

Answer

Nefazodone

Answer

Valethamate

Answer

Varenicline

Question 3

Which of the following is not considered a prokinetic agent?

Accepted Answer

Diphenylmethane

Answer

Dopamine antagonist

Answer

5HT4 agonist

Answer

Macrolides

Question 4

What is the drug of choice (DOC) for prophylaxis of motion sickness?

Accepted Answer

Promethazine

Answer

Prochlorperazine

Answer

Metoclopramide

Answer

Itopride

Question 5

What is the primary use of Pirenzepine?

Accepted Answer

Gastric ulcer

Answer

Glaucoma

Answer

Hypertension

Answer

Congestive cardiac failure

Question 6

What is the drug of choice for preventing chemotherapy-induced vomiting?

Accepted Answer

Granisetron

Answer

Prazosin

Answer

Clonidine

Answer

Dimenhydrinate

Question 7

Main function of sodium citrate in ORS?

Accepted Answer

To correct Acidosis

Answer

To increase absorption of glucose by cotransport

Answer

To correct electrolyte imbalance

Answer

To correct dehydration

Question 8

Which of the following medications is classified as a stool softener?

Accepted Answer

Docusates

Answer

Bran

Answer

Senna

Answer

Phenolphthalein

Question 9

Which of the following drugs is not used for the treatment of H. Pylori?

Accepted Answer

Domperidone

Answer

Bismuth

Answer

Clarithromycin

Answer

Amoxicillin

Question 10

What is the drug of choice for drug-induced peptic ulcer?

Accepted Answer

Proton pump inhibitors

Answer

Prostaglandin analogues

Answer

H2-receptor antagonists

Answer

Antacids

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?